SCHEMBL6958464

SCHEMBL6958464

CC(C)c1ccc(C(C)(C)C)c(Sc2c(O)cc(-c3ccc(OCc4cccnc4)cc3)oc2=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.37
TERT O14746 3/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MDM2 Q00987 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
GRM2 Q14416 1/20 0.35
DHODH Q02127 1/20 0.35
ACACB O00763 1/20 0.35
FFAR1 O14842 1/20 0.35
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
GPR132 Q9UNW8 1/20 0.34
PRKDC P78527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964866 0.91 ADAMTS4 (0.39) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6956214 0.90 NPC1 (0.42) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6963575 0.89 TERT (0.40) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6955620 0.86 NPC1 (0.37) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6959848 0.86 ADAMTS4 (0.40) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6955460 0.85 NPC1 (0.36) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6966162 0.85 MAPK1 (0.39) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
SCHEMBL6955477 0.84 GPR132 (0.36) ADAMTS4TERTNPC1RAB9ASMN1; SMN2
Cyclohexane SCHEMBL6955484 0.84 ADAMTS4 (0.39) ADAMTS4TERTNPC1RAB9ALMNA
Cyclopropane SCHEMBL6955630 0.84 ADAMTS4 (0.39) ADAMTS4TERTNPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed